BlackRock Inc. increased its position in shares of Helius Medical Technologies Inc (OTCMKTS:HSDT) by 9.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 803,164 shares of the company’s stock after acquiring an additional 68,757 shares during the quarter. BlackRock Inc.’s holdings in Helius Medical Technologies were worth $7,862,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently made changes to their positions in the company. Schwab Charles Investment Management Inc. acquired a new position in shares of Helius Medical Technologies during the 2nd quarter valued at about $291,000. Northern Trust Corp acquired a new position in shares of Helius Medical Technologies during the 2nd quarter valued at about $344,000. Finally, Bank of New York Mellon Corp acquired a new position in shares of Helius Medical Technologies during the 2nd quarter valued at about $397,000.

OTCMKTS HSDT opened at $7.42 on Monday. Helius Medical Technologies Inc has a 12 month low of $6.72 and a 12 month high of $13.20.

Helius Medical Technologies (OTCMKTS:HSDT) last posted its earnings results on Thursday, November 8th. The company reported ($0.19) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.23) by $0.04.

Separately, BTIG Research raised shares of Helius Medical Technologies from a “neutral” rating to a “buy” rating and set a $14.00 target price on the stock in a research report on Tuesday, November 20th.

WARNING: This news story was published by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.watchlistnews.com/blackrock-inc-purchases-68757-shares-of-helius-medical-technologies-inc-hsdt/2793889.html.

Helius Medical Technologies Profile

Helius Medical Technologies, Inc is a medical technology company focused on neurological wellness. The Company focuses on developing, licensing or acquiring non-invasive platform technologies that amplify the brain’s ability to heal itself. The Company is engaged in the development of its product, the portable neuromodulation stimulator (PoNS) device.

See Also: Quick Ratio

Want to see what other hedge funds are holding HSDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Helius Medical Technologies Inc (OTCMKTS:HSDT).

Institutional Ownership by Quarter for Helius Medical Technologies (OTCMKTS:HSDT)

Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.